Transcytosis of macromolecules at the blood-brain barrier

Advances in Pharmacology

Volumn 71, Issue , 2014, Pages 147-163

  Preston, Jane E ^a   Joan Abbott, N ^a   Begley, David J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adaptor protein complex 1; Adaptor protein complex 2; Adsorptive mediated transcytosis; Blood brain barrier; Caveolae; Clathrin; Endocytosis; Macropinocytosis; Rab GTPases; Receptor mediated transcytosis

Indexed keywords

ADAPTOR PROTEIN; INSULIN; LIGAND; LIPOPROTEIN; MEMBRANE RECEPTOR; RAB PROTEIN; TRANSFERRIN; DRUG;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; CAVEOLA; CELL MEMBRANE; CELLULAR DISTRIBUTION; COATED VESICLE; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ENDOCYTOSIS; EXOCYTOSIS; HUMAN; LIPID RAFT; MACROMOLECULE; MDCK CELL LINE; NONHUMAN; PINOCYTOSIS; TRANSCYTOSIS; ANIMAL; ENDOTHELIUM CELL; METABOLISM; TRANSPORT VESICLE;

ANIMALS; BLOOD-BRAIN BARRIER; ENDOTHELIAL CELLS; HUMANS; PHARMACEUTICAL PREPARATIONS; TRANSCYTOSIS; TRANSPORT VESICLES;

EID: 84908010477     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/bs.apha.2014.06.001     Document Type: Chapter

References (58)

1. Banks W.A. The source of cerebral insulin. European Journal of Pharmacology 2004, 490:5-12.
2. Banks W.A., Niehoff M.L., Martin D., Farrell C.L. Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene. Brain Research 2002, 950:130-136.
3. Begley D.J. Structure and function of the blood-brain barrier. Enhancement in drug delivery 2007, 575-591. CRC Press, Boca Raton. E. Touitou, B.W. Barry (Eds.).
4. Bien-Ly N., Yu Y.J., Bumbaca D., Elstrott J., Boswell C.A., Zhang Y., et al. Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants. Journal of Experimental Medicine 2014, 211(2):233-244.
5. Bomsel M., Parton R., Kuznetsov S.A., Schroer T.A., Gruenberg J. Microtubule- and motor-dependent fusion in vitro between apical and basolateral endocytic vesicles from MDCK cells. Cell 1990, 62(4):719-731.
6. Bonifacino J.S. Adaptor proteins involved in polarized sorting. Journal of Cell Biology 2014, 204(1):7-17.
7. Brightman M.W. The intracerebral movement of proteins injected into blood and cerebrospinal fluid of mice. Progress in Brain Research 1968, 29:19-37.
8. Brightman M.W., Reese T.S. Junctions between intimately apposed cell membranes in the vertebrate brain. Journal of Cell Biology 1969, 40:648-677.
9. Coomber B.L., Stewart P.A. Three-dimensional reconstruction of vesicles in endothelium of blood-brain barrier versus highly permeable microvessels. The Anatomical Record 1986, 215:256-261.
10. Deane R., Wu Z., Zlokovic B.V. RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier. Stroke 2004, 35:2628-2631.
11. Demeule M., Poirier J., Jodoin J., Berttrand Y., Desrosiers R.R., Dagenais C., et al. High transcytosis of melanotransferrin (P97) across the blood-brain barrier. Journal of Neurochemistry 2002, 83:924-933.
12. Demeule M., Régina A., Ché C., Poirier J., Nguyen T., Gabathuler R., et al. Identification and design of peptides as a new drug delivery system for the brain. Journal of Pharmacology and Experimental Therapeutics 2008, 324(3):1064-1072.
13. Ehrlich P. Das Sauerstoffbedürfnis des organismus 1885, Eine Farbenanalytische Studie, Berlin.
14. Gaillard P., de Visser C.C., Boer A.G. Targeted delivery across the blood-brain barrier. Expert Opinion on Drug Delivery 2005, 2:299-309.
15. Gao H., Yang Z., Zhang S., Pang Z., Jiang X. Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles. Journal of Drug Targeting 2014, 22(5):450-459.
16. Ghaffarian R., Bhowmick T., Muro S. Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1. Journal of Controlled Release 2012, 163(1):25-33.
17. Goldmann E. Vitalfarbung am zentralnervensystem. Abhandlungen der Preussischen Akademie der Wissenschaften 1913, 1:1-60.
18. Granholm A.C., Bäckman C., Bloom F., Ebendal T., Gerhardt G.A., Hoffer B., et al. NGF and anti-transferrin receptor antibody conjugate: Short and long-term effects on survival of cholinergic neurons in intraocular septal transplants. Journal of Pharmacology and Experimental Therapeutics 1994, 268(1):448-459.
19. Grant B.D., Donaldson J.G. Patways and mechanisms of endocytic recycling. Nature Reviews Molecular and Cell Biology 2009, 10(9):597-608.
20. Gravotta D., Carvajal-Gonzalez J.M., Mattera R., Deborde S., Banfelder J.R., Bonifacino J.S., et al. The clathrin adaptor AP-1A mediates basolateral polarity. Developmental Cell 2012, 22(4):811-823.
21. Haqqani A.S., Delaney C.E., Tremblay T.L., Sodja C., Sandhu J.K., Stanimirovic D.B. Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids and Barriers of the CNS 2013, 10(1):4.
22. Hase K., Nakatsu F., Ohmae M., Sugihara K., Shioda N., Takahashi D., et al. AP-1B-mediated protein sorting regulates polarity and proliferation of intestinal epithelial cells in mice. Gastroenterology 2013, 145(3):625-635.
23. Hertz J., Marchang P. Coaxing the LDL receptor family into the fold. Cell 2003, 112:289-292.
24. Heymann J.B., Winkler D.C., Yim Y.I., Eisenberg E., Greene L.E., Steven A.C. Clathrin-coated vesicles from brain have small payloads: A cryo-electron tomographic study. Journal of Structural Biology 2013, 184(1):43-51.
25. Hsu J., Rappaport J., Muro S. Specific binding, uptake and transport of ICAM-1 targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier. Pharmaceutical Research 2014, 31:1855-1866.
26. Huang S., Li J., Han L., Liu S., Ma H., Huang R., et al. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. Biomaterials 2011, 32(28):6832-6838.
27. Huang R., Ma H., Guo Y., Liu S., Kuang Y., Shao K., et al. Angiopep-conjugated nanoparticles for targeted long-term gene therapy of Parkinson's disease. Pharmaceutical Research 2013, 30(10):2549-2559.
28. Humphries A.C., Way M. The non-canonical roles of clathrin and actin in pathogen internalization, egress and spread. Nature Reviews. Microbiology 2013, 11(8):551-560.
29. Lau A.W., Chou M.M. The adaptor complex AP-2 regulates post-endocytic trafficking through the nonclathrin Arf6-dependent endocytic pathway. Journal of Cell Science 2008, 121:4008-4017.
30. Lim J.P., Gleeson P.A. Macropinocytosis: An endocytic pathway for internalising large gulps. Immunology and Cell Biology 2011, 89(8):836-843. 10.1038/icb.2011.20.
31. Mayor S., Pagano R.E. Pathways of clathrin-independent endocytosis. Nature Reviews Molecular Cell Biology 2007, 8(8):603-612.
32. Millán J., Hewlett L., Glyn M., Toomre D., Clark P., Ridley A.J. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nature Cell Biology 2006, 8(2):113-123.
33. Nayak R.C., Keshava S., Esmon C.T., Pendurthi U.R., Rao L.V. Rab GTPases regulate endothelial cell protein C receptor-mediated endocytosis and trafficking of factor VIIa. PLoS One 2013, 8(3):e59304.
34. Niewoehner J., Bohrmann B., Collin L., Urich E., Sade H., Maier P., et al. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle. Neuron 2014, 81(1):49-60.
35. Pan W., Kastin A. Entry of EGF into brain is rapid and saturable. Peptides 1999, 20:1091-1098.
36. Pan W., Kastin A. TNFα transport across the blood-brain barrier is abolished in receptor knockout mice. Experimental Neurology 2002, 174:193-200.
37. Panzenboeck U., Balazs Z., Sovic A., Hrzenjak A., Levak-Frank S., Wintersperger A., et al. ABCA1 and scavenger receptor class B, type 1, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine capillary endothelial cells. The Journal of Biological Chemistry 2002, 277:42781-42789.
38. Pardridge W.M., Eisenberg J., Cefalu W.T. Absence of albumin receptor on brain capillaries in vivo or vitro. The American Journal of Physiology 1985, 249:E264-E267.
39. Razani B., Lisanti M.P. Caveolins and caveolae: Molecular and functional relationships. Experimental Cell Research 2001, 271:36-44.
40. Reese T.S., Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. Journal of Cell Biology 1967, 34:207-217.
41. Régina A., Demeule M., Ché C., Lavallée I., Poirier J., Gabathuler R., et al. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. British Journal of Pharmacology 2008, 155(2):185-197.
42. Sehgal P.B., Mukhopadhyay S. Pulmonary arterial hypertension: A disease of tethers, SNAREs and SNAPs?. American Journal of Physiology. Heart and Circulatory Physiology 2007, 293(1):H77-H85.
43. Serrano D., Bhowmick T., Chadha R., Garnacho C., Muro S. Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology 2012, 32(5):1178-1185.
44. Sly W.S., Vogler C. The final frontier-crossing the blood-brain barrier. EMBO Molecular Medicine 2013, 5:655-657.
45. Smith J.P., Uhernik A.L., Li L., Liu Z., Drewes L.R. Regulation of Mct1 by cAMP-dependent internalization in rat brain endothelial cells. Brain Research 2012, 1480:1-11.
46. Stern D., Yan S.D., Yan S.F., Schmidt A.M. Receptor for advanced glycation endproducts: A multiligand receptor magnifying cell stress in diverse pathologic settings. Advanced Drug Delivery Reviews 2002, 54:1615-1625.
47. Stewart P.A. Endothelial vesicles in the blood-brain barrier: Are they related to permeability?. Cellular and Molecular Neurobiology 2000, 20:149-163.
48. Thompson A., Nessler R., Wisco D., Anderson E., Winckler B., Sheff D. Recycling endosomes of polarized epithelial cells actively sort apical and basolateral cargos into separate subdomains. Molecular Biology of the Cell 2007, 18(7):2687-2697.
49. Ulbrich K., Knobloch T., Kreuter J. Targeting the insulin receptor: Nanoparticles for drug delivery across the blood-brain barrier (BBB). Journal of Drug Targeting 2011, 19(2):125-132.
50. Urayama A., Grubb J.H., Sly W.S., Banks W.A. Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the new born mouse. Molecular Therapy 2008, 16(7):1261-1265.
51. Vercauteren D., Vandenbroucke R.E., Jones A.T., Rejman J., Demeester J., De Smedt S.C., et al. The use of inhibitors to study endocytic pathways of gene carriers: Optimization and pitfalls. Molecular Therapy 2010, 18(3):561-569.
52. Visser C.C., Voorwinden H., Crommelin D.J.A., de Danhof M., Boer A.G. Characterisation of the transferrin receptor on brain capillary endothelial cells. Pharmaceutical Research 2004, 21:761-769.
53. Weisz O.A., Rodriguez-Boulan E. Apical trafficking in epithelial cells: Signals, clusters and motors. Journal of Cell Science 2009, 122(Pt. 23):4253-4266.
54. Wu D., Yang J., Pardridge W.M. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. Journal of Clinical Investigation 1997, 100(7):1804-1812.
55. Xu J., Toops K.A., Diaz F., Carvajal-Gonzalez J.M., Gravotta D., Mazzoni F., et al. Mechanism of polarized lysosome exocytosis in epithelial cells. Journal of Cell Science 2012, 125(Pt. 24):5937-5943.
56. Yoshikawa T., Pardridge W.M. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor. Journal of Pharmacology and Experimental Therapeutics 1992, 263(2):897-903.
57. Yu Y.J., Zhang Y., Kenrick M., Hoyte K., Luk W., Lu Y., et al. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Science Translational Medicine 2011, 3:84ra44.
58. Zlokovic B.V., Skundric D.S., Segal M.B., Lipovac M.N., Makic J.B., Davson H.A. Saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig. Experimental Neurology 1990, 107:263-270.